Literature DB >> 15888806

Adalimumab use in pregnancy.

L Vesga, J P Terdiman, U Mahadevan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15888806      PMCID: PMC1774554          DOI: 10.1136/gut.2005.065417

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  7 in total

1.  Using an analogous monoclonal antibody to evaluate the reproductive and chronic toxicity potential for a humanized anti-TNFalpha monoclonal antibody.

Authors:  G Treacy
Journal:  Hum Exp Toxicol       Date:  2000-04       Impact factor: 2.903

2.  A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

Authors:  S R Targan; S B Hanauer; S J van Deventer; L Mayer; D H Present; T Braakman; K L DeWoody; T F Schaible; P J Rutgeerts
Journal:  N Engl J Med       Date:  1997-10-09       Impact factor: 91.245

Review 3.  Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease.

Authors:  U Mahadevan; S Kane; W J Sandborn; R D Cohen; K Hanson; J P Terdiman; D G Binion
Journal:  Aliment Pharmacol Ther       Date:  2005-03-15       Impact factor: 8.171

4.  Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease.

Authors:  Filip Baert; Maja Noman; Severine Vermeire; Gert Van Assche; Geert D' Haens; An Carbonez; Paul Rutgeerts
Journal:  N Engl J Med       Date:  2003-02-13       Impact factor: 91.245

5.  Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.

Authors:  Stephen B Hanauer; Brian G Feagan; Gary R Lichtenstein; Lloyd F Mayer; S Schreiber; Jean Frederic Colombel; Daniel Rachmilewitz; Douglas C Wolf; Allan Olson; Weihang Bao; Paul Rutgeerts
Journal:  Lancet       Date:  2002-05-04       Impact factor: 79.321

6.  Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis.

Authors:  Jeffry A Katz; Christian Antoni; Gregory F Keenan; Deirdre E Smith; Stephen J Jacobs; Gary R Lichtenstein
Journal:  Am J Gastroenterol       Date:  2004-12       Impact factor: 10.864

7.  An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn's disease.

Authors:  William J Sandborn; Stephen Hanauer; Edward V Loftus; William J Tremaine; Sunanda Kane; Russell Cohen; Karen Hanson; Therese Johnson; Debra Schmitt; Resa Jeche
Journal:  Am J Gastroenterol       Date:  2004-10       Impact factor: 10.864

  7 in total
  30 in total

Review 1.  Fertility and pregnancy in the patient with inflammatory bowel disease.

Authors:  U Mahadevan
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

2.  Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006.

Authors:  D E Furst; F C Breedveld; J R Kalden; J S Smolen; G R Burmester; P Emery; E C Keystone; M H Schiff; P L C M van Riel; M E Weinblatt; M H Weisman
Journal:  Ann Rheum Dis       Date:  2006-11       Impact factor: 19.103

Review 3.  Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007.

Authors:  D E Furst; F C Breedveld; J R Kalden; J S Smolen; G R Burmester; J Sieper; P Emery; E C Keystone; M H Schiff; P Mease; P L C M van Riel; R Fleischmann; M H Weisman; M E Weinblatt
Journal:  Ann Rheum Dis       Date:  2007-11       Impact factor: 19.103

4.  Pregnancy, Fertility, and Therapies for IBD.

Authors:  Uma Mahadevan
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-04

5.  Inflammatory bowel disease in pregnancy.

Authors:  Dawn B Beaulieu; Sunanda Kane
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

Review 6.  Arthritis in pregnancy: the role and safety of biological agents.

Authors:  Peter Youssef; Debra Kennedy
Journal:  Obstet Med       Date:  2009-11-30

7.  Safety of Tumor Necrosis Factor Inhibitors during Pregnancy and Breastfeeding.

Authors:  Harish Raja; Eric L Matteson; Clement J Michet; Justine R Smith; Jose S Pulido
Journal:  Transl Vis Sci Technol       Date:  2012-09-21       Impact factor: 3.283

8.  Adalimumab for the treatment of Crohn's disease.

Authors:  Andrea Cassinotti; Sandro Ardizzone; Gabriele Bianchi Porro
Journal:  Biologics       Date:  2008-12

9.  The use of anti-TNFα medications for rheumatologic disease in pregnancy.

Authors:  Megan Eb Clowse
Journal:  Int J Womens Health       Date:  2010-08-09

Review 10.  [Systemic psoriasis therapy - the next step. Adalimumab].

Authors:  G Wozel; M Sticherling
Journal:  Hautarzt       Date:  2007-06       Impact factor: 0.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.